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Abstract 
Turbidity and differential scanning calorimetry measurements revealed the plant derived antineoplastic soflavone, 
daidzein, to bind to large unilamellar liposomes. Comparing different unsaturated phospholipids most pronounced 
aggregation due to daidzein was observed tbr phosphatidylinositol (Pl) while the inclusion of cholesterol strongly attenuated 
the aggregation. Interestingly, aggregation was not observed |br the structurally very closely related isoflavone, genistein. 
The extent of aggregation was nonlinearly dependent on the content of P! in egg phosphatidylcholine (eggPC) vesicles. The 
saturated dimydstoyl phosphotipids, phosphatidylserine, phosphatidylcholine, phosphatidic a id, as well as phophatidylglyc- 
erol were also extensively aggregated by daidzein at IO°C, i,e,, below their main phase transition temperature whereas their 
aggregation at 35°C in the fluid phase was strongly reduced. Vesicle aggregation could be accompanied by membrane 
fusion, however, neither contents mixing nor lipid mixing of the LUVs (large unilamellar vesicles) was observed in the 
presence of daidzein. Strong perturbation of the thermal phase beha,'iour of both dimyristoyl phosphatidylcholine (DMPC) 
and dimydstoyl phosphatidylserine (DMPS) muhilamellar ve,,.icle~,: I~,, daidzein was revealed by differential scanning 
calorimetry. More specifically, for DM~ increasing quantities of daidzein progressively decreased both the main transition 
temperature Tm and its enthalpy whereas for DMPS a decrease in 3H was not observed, thus indicating the modes of 
interaction of daidzein with these phospholipids todiffer. Our results indicate daidzein to reside in the polar beadgroup/in- 
terfacial region of Pi and PS membranes, The interactions ol daidzein with phospholipids could represent an additioneJ 
contributor to the growing list of effects of this isofluvone on cellular functions, 
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1. Introduction 
Plants provide a rich source of pharmaceutically 
active agents, ranging trom toxins and carcinogens to 
chemopreventivc compounds. Epidemiological stud- 
ies have reve~ded the traditional soy-based Asi;,.u diet 
to be associated with a diminished risk fo, cancer 
[I-4]. It has long been known that soybeans contain 
isoflavones, mainly genistein (5.7.4'-trihydroxyiso- 
flavone) and daidzein (7,4'-dihydroxyisoflavone) [5] 
(see Fig. 1. tbr the chemical structures). These com- 
pounds were identified in human biological fluids 
[6-8] and particularly high concentrations were tbund 
in the plasma and urine of subjects on traditional 
Japanese diet [9,10]. Importantly, the levels are high 
enough to suggest hat these plant-derived compo- 
nents may exert cancer protective ffects in vivo, as 
follows. These compounds have numerous biological 
activities in vitro [31,32], among the most interesting 
being inhibition oi proliferation of various cancer cell 
lines and induction of differentiation of leukemic 
cells [11-26,64,65]. (3enistein and to a much lesser 
degree also daidzein are inhibitors of protein tyrosine 
kinases [27-29]. Genistein as well as to some extent 
also daidzein were shown to inhibit malignant anglo- 
genesis at physiological concemrations in vitro [30]. 
To this end, several anticancer compounds uch ~s 
adriamycin, daunomycin, taxol and ET-18-OCH~ (an 
antineoplastic etherphospholipid) nteract with mem- 
branes and this property has been suggested to play a 
role in their naechanis'm, of action [33-36]. 
The lipophilicity of daidzein readily suggests that 
this compound should interact with biological mem- 
branes. Certain tqavonoids, i.e., quercetin, hesperetin, 
and narintm~in were recently demonstrated to parti- 
tion into liposomal bilayers as revealed by differen- 
tial scanning, calo,imctry [66]. In the present study, 
daidzein was found to associate with phospholipids, 
as shown by turbidity and by differential scanning 
Fig. I. The chemiczd ~,trtlcltlrc:, of dmd/ein {R = H) alld Stub, rein 
(R =OH). 
calorimetry measurements. Binding of this compound 
to large unilamellar vesicles PI resulted in their ag- 
gregation whereas this was not observed for the 
structurally closely rela;ed isoflavone, genistein. Our 
results further show that the structural and physical 
requiremems for daidzein induced aggregation are 
best met by liposomes composed of either fluid Pl or 
gel phase DMPS. Daidzein also alters the physical 
properties of liposomal membranes, evident as 
changes in the thermal phase behaviour upon DSC. 
The possible consequences of the lipid association of 
daidzein are discussed. 
2. ~aterials and methods 
2. I. Materials 
DMPS was from Alexis (L~iufelfingen, Switzer- 
land), and brainPS, PI, DMPC, DMPG, eggPG, 
sphingosine, and cardiolipin were from Sigma, EggPC 
as well as the labelled phospholipids, NBD-PE and 
Rh-PE, were from Avanti Polar lipids (Alabaster, 
AL, USA}. No impurities were detected in any of the 
above lipid~ upon thin-layer chromatography onsilt- 
tic acid coated plates (Merck, Darmstadt, Germany) 
using chloroform/n,ethanol/water (65:25:4, v/v) as 
the solvent system and examination of the plates after 
iodine staining. The concentrations of the nonfluores- 
cent phospholipids were determined by phosphorus 
assay [37]. Daidzein was synthesized as described 
previously [7] and genistein was from Karl Roth 
GmbH (l,'arlsruhe, Germany). 
2.2, ttpo.~'ome preparation 
Lipids were dissolved in chloroform and alter 
mixing of the desired ,'ompositions the solvent was 
removed under a stream of nitrogen. The dry lipid 
residues were then maintained under reduced pres- 
sure lbr one hour and subsequenlly hydrated in 20 
mM Tris, 0.1 mM EDTA, pH 7.4, at least IO°C 
above the gel ~ liquid crystalline transition tempera- 
ture (T,,,) of the phospholipid in question. To obtain 
large unilamellar vesicles (LUVs) the dispersions 
were extruded through Millipore (Bedlbrd, MA, USA) 
0.1 #m pore size polycarbonate filters usin,., ~, Li- 
posoFast low pressure homogenizer (Avestit,,. Ot- 
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tawa. Canada) essentially as described [38.39]. Re- 
suiting dispersions were optically clear. 
2.3. Tm'bidin' meas,rements 
a..re.atmn As a qualitative stimate of liposome 'Sg , ,' 
absorbance was measured at 400 nm using a Shi- 
madzu Graphicord spectophotometer and quartz ctt- 
vettes with an optical path of I cm. We observed 
daidzein to adsorb to cuvettes and therefore thei~ 
careful cleaning was important. Unless otherwise 
specified experiments were pertbrmed at 25°C in 20 
mM Tris, 0.1 mM EDTA. pH 7.4 and at a lipid 
concentration f 50/,M. Daidzein as well as genis. 
tein were added as ethanol solution (2 mg/ml). 
Daidzein but not genistein has a tendency to crystal- 
lize in ethanol solution. Therefore, to ensure com- 
plete solubility solutions used were heated and vigor. 
ously mixed prior to use. As a control ethanol was 
added to vesicles and caused no turbidity changes 
whatsoever. Likewise. the addition of daid:ein to 
buffer in the absence of lipid had no inllueltce on 
m 401P 
2,4. Lipid mixi;~g 
For the resonance nergy transfer assay, I tool% 
each of NBD-PE and Rh-PE were incorporated into 
liposomes [40]. Under these conditions, NBD fl.uores- 
cence was quenched by Rh. These labelled liposomes 
were subsequently mixed in an overall phospholipid 
stoichiometry of 1:9 with vesicles containing no fluo- 
rescent lipids. NBD fluorescence at 530 nnt was 
recorded continously using excitation at 455 nm, 
Lipid mixing would be evident as an increase of 
fluorescence r sulting from the dilution of the fluo- 
rescent lipids into unlabelled liposomex which de- 
creases the efficiency of resonance nergy transfer 
between NBD and Rh. 
2.5. Aqt~eotts co~lte~st.~ mLO L 
The assay for monitoring the mixing of the aque- 
ous contents upon ,,esicle fusion is based on the 
collisionai quenching of ANTS by DPX upon merg- 
ing. of the vesicles [41]. Vesicles were prepared in 
either 25 mM ANTS/45 mM NaCI/0.1 mM EDTA, 
20 mM Tris, and pH 7.4 or 90 mM DP×/0.1 mM 
EDTL, 20 mM Tris. pH 7.4, There was ao signific~mt 
osmotic gradient across the membrane during the 
measurement [41]. Vesicles containing either AN'I'S 
or DPX were subsequently mixed in the cuvette. The 
flttorescencc s ale was set such that vesicles encap:~u- 
lating both ANTS and DPX represented 0% fluores- 
cence (complete fusion) whereas vesicles containing 
only ANTS ~ielded 100% fluorescence (no fusion}. 
Excitation was at 360 nm and emission at 530 mat 
2.6. l)i[#rellthd scam~b~g calorimetry (DSC) 
Liposomes were prepared by evaporating the 
drug/!ipid mixtures it~t chloroform to dryness under a 
stream of nitrogen, the dry lipid residues were then 
maintained under educed pressure for m'ernight and 
thereafter hydrating the samples with the buffer abme 
the main transition temperature of the lipid in ques- 
tion tt) obtain a lipid concentration f 0.7 raM. After 
hydration salrlples were cooled to O°C and allowed to 
equilibrate at least overnight, DSC naeasuret,ents 
were peflormed using a high sensitivity calorimeter 
DASM-4 (Biopribor, Pushchino. Russia) at a heating 
rate of 0.SC'/min. The transition enthalpies were 
determined by planimetry of the peaks using the 
internal electrical power calibration signal as a refer. 
elIce. 
3. Results 
3. I. Aggn,,,,,atioll of LUVs 
Addilion of daidzein to PI LUVs caused an in- 
c:case ill absorbance at 400 nm, indicating vesicle 
aggregation. Fig. 2a. This effect of daidzein was not 
specific for P! and aggregation was observed also for 
other unsaturated phospholipid.,,, the extent of drug- 
induced tt, rbidity increase dirninishing in the se- 
quence PI > PS > PG > PA > PC. Fig. 2a. Binding 
of daidzcin to Pl was rapid and maximal increase in 
turbidity was reached within approximately six min- 
utes after the addition of the drug. In contrast o the 
above ph,,,,phdipids, no turbidity changes were ob- 
served for vesicles composed of tardiolipin or sphin- 
cosine (data not shown). On the timescale (30 mitt) 
of our measurements and at drug/lipid stoichiornetry 
of 2.4:1 the structurally closely related isoflavone, 
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genistein, had essentially no effect on the absorbance 
of the vesicles composed of any of the lipids usde in 
the present study (data not shown). 
We then studied the possibility that the phase state 
of the phospholids could be important for daidzein 
induced vesicle aggregation• For this purpose daidzein 
wa:, added at a drug/lipid ratio of 2.4:1 to LUVs of 
different dimyristoyl phospholipids. Fig. 2b. At 35°C, 
i.e., above the main transition temperature, most in- 
tensive aggregation was evident with DMPS. The 
timescale of aggregation (maximal increase in turbid- 
ity within I0 min) was comparable to brainPS. When 
aggregation was measured at 10°C (below the T m 
values of the phospholipids used) the extent of turbid- 
ity increase for these dimyristoyl lipids was consider- 
ably higher (approx. 3-fold) than in the liquid crys- 
talline state, thus indicating more vigorous aggrega- 
tion, Fig, 2c, This would suggest that it is the proper- 
ties of the membrane surface that determine the 
aggregation of vesicles, Again, of the phospholipids 
studied DMPS exhibited the most intense aggresa- 
tion, the absorbance increasing from 0.2 to 0.6 within 
5 minutes. Similar effect was also observed for DPPC 
(T,., = 41°C). For this lipid in the gel phase daidzein 
induced a rapid aggregation of vesicles whereas at 
50°C the extent of absorbanee increase due to daidzein 
was strongly attenuated. 
We then proceeded to study the dependency of 
aggregation of brainPS and PI LUVs on [daidzein]. 
Lipid concentration was held constant at 50 ,,.M 
while increasing amounts of daidzein were added, 
Fig. 3. Aggregation of these vesicles by daidzein 
appeared to be critically dependent on the drug/lipid 
Fi;g, 2, (a) Time courses of duidzein duced turbidity changes for 
large unilamellar vesicles composed of yeastPi (|}. hrainPS 
(O), eggPO (• ), eggPA (~' ), or eggPC (• ). The concentration 
of lipids was 50 ,aM in 20 mM Tris, 0.1 mM EDTA, pH 7.4, and 
measurements were conducted at 25°C, Daidzein was dissolved 
in ethanol (2,0 mg/ml) and was added to yield a 2.4:1 drug/lipid 
molar atio (i.e,, 120 nmol of daidzein i  15,5 ~.1 ethanol). The 
s:nnple was subseqnemly vigorously mixed by vonexing prior to 
the measurement of A4(,), (b) Aggregation f LUVs composed of 
DMPS (I), DMPG ( • ), DMPA ( t ), or DMPC ( w ) by daidzein 
at 35°C. The daidzein/lipid ratio as well as other conditions were 
otherwise identical to those described for panel a, (c) Lipids and 
experimental conditions were as for panel b except that empera- 
ture was IO°C. 
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Fig. 3. Aggregation f yeastP1 ( 1), and brainPS (O} vesicles at
varying concentrations f daidzein. Lipid concentration was 50 
p.M. Absorbance at 4IX) nm was measured after a 15 nain of 
incubation at 25°C. Conditions were otherwb, e as ft~r Fig, 2. 
ratio and a steep increase in turbidity occurs tbr PI 
upon reaching 2.2:1 stoichiometry. Below this stoi- 
chiometry only minor turbidity changes upon increas- 
ing [daidzein] were evident and as judged by ab- 
sorbance the extent of aggregation of brainPS and PI 
vesicles was significantly reduced and comparable to 
that of eggP£ LUVs. 
3.2. Lipid mixing attd contents mLring 
To determine whether bilayer fusion occured ur- 
ing the daidzein-induced aggregation of vesicles both 
lipid as well as contents mixing assays were em- 
ployed as described under Section 2. However, no 
evidence for these processes was obtained thus sug- 
gesting lack of fusion of bilayers during the aggrega- 
tion of the vesicles (data not shown). 
3.3. Dependency of aggregation on the acidic phos- 
pholipid content in eggPC 
As shown above, unsaturated PI and brainPS vesi- 
cles were aggregated by daidzein whereas this was 
not the case for eggPC liposomes. Accordingly. we 
then characterized the dependency of daidzein-in- 
duced aggregation of LUVs on the content of PI, 
brainPS, or eggPG in eggPC, For this purpose, vest- 
,des with different acidic phospholipid/eggPC molar 
ratios were prepared. Both yeastPI and brainsPS 
LUV.~ showed marked sensitivity on their content in 
eggPC, Fig. 4. Varying the amount of PI in eggPC 
between 40 and 90 tool% caused clearly nonlinear 
changes in the daidzein induced aggregation, Interest- 
ingly, for brainPS/eggPC vesicles more vigorous 
aggregation was seen at lower contents of brainPS, 
reaching maximum at 05 mot~ of the acidic lipid, 
For eggPG only rather small variation in the drug-in- 
duced aggregation of the different eggPG/eggP£ 
mixtures was observed, Fig, 4. 
3,4. Effect ¢!t cholesterol and ionic strength 
Intcrestinoly:,, already IO mot% of cholesterol in a 
PI matrix strongly reduced the extent of daidzein 
induced vesicle aggregation, evident as a = 50% 
attenuation i absorbance increase at 400 nm, Fig. 5. 
However, increase in the cholesterol content up to 30 
tool% does not lead to significant further eduction i  
aggregation. Increasing concentrations of NaC1 de- 
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% J. I/.A. Lehtom'~ etal./Biochimica et Bi~q~hy.dc, A ra 1285 (I 996) 91- I00 
0,5 ...... 
A450 
0.4 
0,3 
0,2, 
O0 • i , , ' 
0 10 20 30 
Cholesterol, mol% 
Fig. 5. Inllucnce of the content of cholesterol ~ the aggregation 
of ycastPI LUV~, by daidzein. Aa~ was measured after u 15 rain 
incubation al ~ ° .5 C. Conditions were otherwise as de.~cribed in the 
caption for Fig. 2. 
creased aggregation of yeastPl LUVs by daidzein, 
Fig. 6. More specifically. 50 mM NaCI reduced the 
extent of aggregation by 50c~ whereas at hi,~her ,..ah 
concentrations no further decrease coud be observed. 
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3.5. Differential scamfing calorimetry 
Upon a temperature scan from Iff'C to 30°C the 
presence of daktzein at a I:1 drug/l ipid ratio de- 
creased the T,~ of DMPC from 25.0 to 23.5°C. Like- 
wise. increasing contents ef .,aidzein progressively 
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J.Y.A. Lehtom'n etal./ Biochimica ct fCio2hy~ica ..Iota 12S5 ¢1cfc)6~ 91-100 97 
reduced the main transition enthalpy ..IH,,, from 28 to 
18 kJ/mol, Fig. 7a. The main transition peak was 
also broadened, revealing reduction in transition co- 
operativity. Pretransition of DMPC which occurs at 
15°C was abolished already at I:10 drug/lipid ratio. 
The above results uggest that daidzein could at least 
partly reside in the hydrocarbon region of DMPC 
MLVs. 
Although of smaller magnitude, ffects quantita- 
tively similar to those described above for DMPC 
were observed also for DPPC. In brief, the transition 
temperatures and enthalpies decreased tbr both the 
pretransition a d main transition. Accordingly. at the 
drug/lipid ratio of 0.65:1 T,. of DPPC decreased 
from 41.6°C to 41.3°C while 514,,, was reduced fi'ont 
39.4 kJ/mol to 32.5 kJ/mol. For comparison, at a 
0.65:1 drug/lipid ratio, genistein, a close structural 
analog of daidzein, reduced the 11, of DPPC to 
:i.0.7°C and AH,n to 33,0 kj/rnol. 
Both daidzein and genistein reduced the enthalpy 
as well as temperature of the prctransition of DPPC 
in a concentration dependent manner. Thus, daidzein 
at a Orug/lipid stoichiometry of !:l suppressed Tpof 
DPPC from 35.5°C to 33.5°C and its enthalpy t>om 
7.4 kJ/mol to 3.5 kJ/mol. With genistein, these 
values were 32°C and to 4.3 kJ/mol, respectively. 
Under the conditions of our calorimetry scans 
DMPS revealed an endotherm at31.2°C. This transi- 
tion temperature decreased along with increasing 
daidzein content o 28°C. Fig. 7b. In contrast o 
DMPC, the enthalpy of DMPS MLVs is slighly 
increased upon the inclusion of increasing quantities 
of daidzein (up to I:1 drug/lipid ratio). 
4. Discussion 
The present results clearly demonstrate daidzein to 
incorporate into phospholipid bilayers, afl'ecting their 
thermal phase properties and causing the aggregation 
of liposomes composed of acidic phospholipids. Ag- 
gregation studies comparing different phospholipids 
revealed that DMPS and PI exhibit most intensive 
aggregation by daidzein whereas above the T,, for 
DMPC no change in the absorbance occurs. Aggrega- 
tion was not observed for the structurally closely 
related isoflavone, genistein. Interestingly. increasing 
[daidzein] decreases the T,, as well as the JH,, of 
DMPC while lor DMPS T,, decreases and the en- 
thalpy is increased. These data den'onstrate that 
daidzein interacts with both DMPC and DMPS but 
the modes of interaction are different. At pH 7.4 
daidzein is pa,tly deprotonated and bears a net nega- 
tive charge. Therefore. the association of daidzein 
with PS and Pl is probably not electrostatic in nature. 
Likewise. membrane assoc@ion of daidzein .ould 
enhance its depmtonation. 
The chemk :,': structure of dai,!zein readily s,- gests 
it to iocat,~ in ti,e interracial region of the membrane. 
The structure of this region is a complex mixture of 
uater, glycerol, carbonyL and methylene groups and 
tbr a lipid such as dioleoyl phosphatidylcholine t 
accottnts for half of the total thermal thickness of the 
bilayer [42]. More specificalb., the interracial region 
resides between the more superficial hydrated polar 
headgroup region of the amphiphilic lipids adjacent 
to bulk water and the hydrocarbon i terior. Incorpora- 
tion of antphiphilic tri?eptides in the bilayer is driven 
by hydrophobic interactions while also hydrogen 
bonding is important for the rnembrane incorporation 
of these compounds [43]. Although the Ihnitations of 
our data make it too preliminary to dwell in more 
detail on the location of daidzein in bilayers it is 
rather clear that similar mechanisms should be rele- 
vant also tbr daidzein. Various attracting and repuls- 
ing tortes govern the aggregation f vesicles and the 
minimal energy state of the system is determined by 
their balance. While vesicles are mutually attracted 
by van tier Waals interactions electrostatic repulsion 
prevails between vesicles composed of phospholipids 
with a net negative charge. At separation distances of 
< 10 A vesicle interaction is dominated by the 
strongly repulsive hydration force which at small 
separatiorls i attributed to the energy required to 
remove water as the vesicle-vesicle s paration dis- 
tance decreases [44]. Hydration. in turn. arises from 
the interaction of polar headgroup region with the 
adjacent water layer by hydrogen bonding. Phos- 
phatidylserine and phosphatidylinositol areboth neg- 
atively charged phospholipids and are both strongly 
hydrated in the absence of Ca-' + [45,46]. The impor- 
tance of the hydration force in preventing the fusion 
of liposomes i  readily evident by comparing poorly 
hydrated phospholipids such kS phos- 
phatidylethanohunine, or phosphatidylserine  the 
presence of Ca -` + which aggregate and fuse much 
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more readi]y when compared to the strongly hydrated 
lipids, such as phosphatidylcholine [47]. Aggregation 
of the liposomes by daidzein clearly reveal that the 
properties of the bflayer surface must be rather drasti- 
cally influenced by this compound. Changes in lipid 
hydration could be involved. In keeping with this 
notion the inclusion of increasing amounts of choles- 
terol into yeastPI vesicles decreased the extent of 
their daidzein induced aggregation. Cholesterol has 
been shown to increase hydration of phospholipid,,; 
[67]. Also increasing [NaCI] attenuated the extent of 
vesicle aggregation by daidzein. This effect could be 
related to changes in the polar headgroup conforma- 
tion [48]. 
Aggregation or close approach of vesicles is a 
prerequisite for the fusion of liposomes. The mecha- 
nisms of liposome fusion have been intensively stud- 
ied [49] and it is clear that tl'.e ability of the fusion 
promoting lipids to form the inverted hexagonal phase 
Htl is closely related to this phenomenon [50,51]. 
Although PS may, under proper conditions, form the 
so-called cochleate structures neither brainPS nor 
yeastPI have been reported to form the H, phase 
[52]. Interestingly, the absence of contents mixing as 
well as lipid mixing of brainPS and yeastP! vesicles 
indicates that they do not fuse due to daidzein, The 
absence of lipid mixing also indicates that there is no 
hemifusion of these vesicles which occurs for in- 
stance when PS or PA vesicles are aggregated by 
Mg 2+ [53,54], 
Our results show that the structural and physical 
requirements for daidzein indu':ed aggregation are 
best met by liposomes composed of fluid PI and gel 
phase DMPS. The extent of aggregation also depends 
in a clearly nonlinear manner on the surface concen- 
tration of yeastPI in eggPC vesicles. Consequences of 
drttg-induced changes in the physteal properties of 
membranes are in general poorly understood. Yet, 
interactions of daidzein with phospholipids could rep- 
resent an important contributor to the growing lisl of 
effects of daidzein on cellular functions. The concen- 
trations of daidzein used in these experiments are 
si.nilar to those c~using inhibition of cell growth [55]. 
hi general binding of peptides and drugs to nlem- 
branes has been suggested to concentrate drugs to 
surfaces facilitating the binding of drugs and peptide 
hormones to :.heir receptors [56-58]. Daidzein might 
alter the phosphoinositide-protein interactions in 
membranes [59]. Both PI and PS arc though to be 
located in the inner leaflet of plasma membranes and 
have been suggested to exist in domains [60]. The 
inositol phospholipids further serve as important sub- 
strates for specific phospholipases C. Protein kinase 
C requires in addition to Ca :+ and diacylglycerol 
also phosphatidylserine for activity [61-63]. Our re- 
sults allow us to hypothesize that daidzein could bind 
in the polar headgroup/interfacial region of mem- 
brane domains enriched in PI and PS and subse- 
quently interfere with the association of PI- PLC and 
PI-kinases and PKC with these acidic phospholipids. 
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